%.
Values statement
In making this recommendation, guideline developers
placed a relatively high value on avoiding the potential
downsides of an invasive procedure in the clinical context of
low risk patients with unclear risk-to-benefit ratio. In these
patients, medical therapy may provide sufficient reduction
in the risk of events at a favorable risk-to-benefit ratio.
Furthermore, in medically high-risk patients it seems likely
that in the absence of symptoms, medical therapy will be
safer than either